[Evolution of the USP and IPSS score after continuous positive airway pressure sleep apnea therapy at night].

Évolution du score USP et IPSS après appareillage du syndrome d’apnées du sommeil par pression positive continue nocturne.
Continuous positive airways pressure Lower urinary trac symptoms Nocturia Nycturie Sleep apnea syndromes Symptômes de l’appareil urinaire inférieur Syndromes d’apnées du sommeil Ventilation en pression positive continue

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 13 10 2020
revised: 29 11 2020
accepted: 20 12 2020
pubmed: 24 6 2021
medline: 15 2 2022
entrez: 23 6 2021
Statut: ppublish

Résumé

To assess the impact of nocturnal continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) on lower urinary tract (LUTS) symptoms. A prospective, monocentric study was conducted between June 2018 and August 2019. Patients with moderate to severe OSA with an indication for treatment with nocturnal CPAP in combination with SBAU were included. SBAUs and their impact were evaluated by completing two self-administered questionnaires (Urinary Symptom Profile (USP) and International Prostate Score Symptom (IPSS)) filled out during the night-time ventilatory polygraph or diagnostic polysomnography for OSA and after 4 months of CPAP treatment. In 79 patients, after four months of CPAP treatment, USP scores for stress urinary incontinence and overactive bladder were significantly improved, respectively 0.65±1.38 vs 1.13±2.10 ; p<0.0001 and 3.24±2.58 vs 5.43±3.66 ; p<0.0001, IPSS and IPSS-Qdv were significantly improved, respectively 5.20±3.78 vs. 7.44±5.05 ; p<0.0001 and 1.93±1.26 vs. 2.27±1.56 ; p=0.002 as well as IPSS score items on pollakiuria, urgency and nocturia. Treatment with CPAP significantly improved SBAU in four months. Testing urology patients for symptoms of OSA in urology patients seeking SBAU would allow referral of patients suspected of OSA to a specialist for diagnosis and management if necessary.

Identifiants

pubmed: 34158219
pii: S1166-7087(21)00001-4
doi: 10.1016/j.purol.2020.12.018
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

130-138

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

R Seret (R)

Service d'urologie, centre hospitalier universitaire Reims, rue du Général-Koenig, 51100 Reims, France. Electronic address: rseret@chu-reims.fr.

C Launois (C)

Service des maladies respiratoires, unité de sommeil et ventilation, centre hospitalier universitaire Reims, 51100 Reims, France.

C Barbe (C)

Service de santé publique et d'aide méthologique, centre hospitalier universitaire Reims, 51100 Reims, France.

S Larre (S)

Service d'urologie, centre hospitalier universitaire Reims, rue du Général-Koenig, 51100 Reims, France.

P Léon (P)

Service d'urologie, clinique Pasteur, 17200 Royan, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH